Comparative Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity or Overweight: A Systematic Review and Network Meta-Analysis. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.